Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • ellid@ymail.com ellid Aug 18, 2014 11:38 AM Flag

    Why Synta Pharmaceuticals Corp. Shares Skyrocketed By Brian Pacampara July 29, 2013

    Why Synta Pharmaceuticals Corp. Shares Skyrocketed
    By Brian Pacampara | More Articles | Save For Later
    July 29, 2013 | Comments (1)

    Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

    What: Shares of biotechnology company Synta Pharmaceuticals Corp. (NASDAQ: SNTA ) soared a whopping 43% today, after results from a mid-stage study of its drug ganetespib in breast cancer patients warranted an expansion of the study.

    So what: Synta said that ganetespib helped enough patients with triple-negative breast cancer to support a second stage of the trial, reinforcing optimism over the drug's blockbuster potential of treating different types of cancers. In fact, according to the American Cancer Society, triple-negative breast cancer is particularly fast-spreading and difficult to treat, so the surprising results should help Synta garner some big-pharma partnership support as well.

 
SNTA
2.30-0.07(-2.95%)Mar 26 4:00 PMEDT